Company Profiles

driven by the PitchBook Platform

Prolacta Bioscience

Description

Provider of life sciences based medical platform intended to advance the science of human milk. The company's life science based medical platform develops human milk-based neonatal nutritional products for critically ill and premature infants in neonatal intensive care units, with the quality and safety of nutritional products made from donor breast milk as well as operates pharmaceutical-grade manufacturing facility for the processing of human milk, providing health care professionals with formulations of human milk for the immunological and nutritional needs of the most fragile babies.

1999

Founded

PRIVATE

Status

51-200

Employees

2ndary - Private

Latest Deal Type

$74.6M

Total Amount Raised

14

Investors

Description

Provider of life sciences based medical platform intended to advance the science of human milk. The company's life science based medical platform develops human milk-based neonatal nutritional products for critically ill and premature infants in neonatal intensive care units, with the quality and safety of nutritional products made from donor breast milk as well as operates pharmaceutical-grade manufacturing facility for the processing of human milk, providing health care professionals with formulations of human milk for the immunological and nutritional needs of the most fragile babies.

Website:

www.prolacta.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology
Other Healthcare Services
Pharmaceuticals

Primary Office

757 Baldwin Park Boulevard Industry, CA 91746United States +1 (626) 599-9260
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Prolacta Bioscience's full profile, request a free trial.

Prolacta Bioscience Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Prolacta Bioscience Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Prolacta Bioscience Investors (14)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Aisling CapitalVenture CapitalMinority000 0000000 0000
Alta PartnersVenture CapitalMinority000 0000000 0000
Arcturus CapitalVenture CapitalMinority000 0000000 0000
Draper AssociatesVenture CapitalMinority000 0000000 0000
Draper RichardsVenture CapitalMinority000 0000000 0000
Aisling Capital Venture Capital
Alta Partners Venture Capital
Arcturus Capital Venture Capital
Draper Associates Venture Capital
Draper Richards Venture Capital

Prolacta Bioscience Executive Team (12)

NameTitleBoard
Seat
Contact
Info
Scott ElsterChief Executive Officer & Board Member
David DreyerChief Financial Officer
Yang YuChief Information Officer
Mark WisniewskiHead of Special Projects
Martin Lee Ph.DVice President, Clinical Research and Development
Scott Elster Chief Executive Officer & Board Member
David Dreyer Chief Financial Officer
Yang Yu Chief Information Officer
Mark Wisniewski Head of Special Projects
Martin Lee Ph.D Vice President, Clinical Research and Development

Prolacta Bioscience Board Members (11)

NameRepresentingRoleSinceContact
Info
Alison KileyAlta PartnersDirector000 0000
Daniel JanneyAlta PartnersManaging Director000 0000
David Brailer Ph.DHealth Evolution PartnersChairman, Managing Partner, Chief Executive Officer000 0000
Ernie Strapazon Ph.DSelfBoard Member000 0000
Frank FosterThe Gideon Hixon FundManaging General Partner000 0000
Alison Kiley Director Alta Partners
Daniel Janney Managing Director Alta Partners
David Brailer Ph.D Chairman, Managing Partner, Chief Executive Officer Health Evolution Partners
Ernie Strapazon Ph.D Board Member Self
Frank Foster Managing General Partner The Gideon Hixon Fund
Request full access to PitchBook